Publications by authors named "P Seeldrayers"

Claim this Profile
L
Long-Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European Countries.
Melinda Magyari, Alice Koechlin, Antoine Duclos, Tine Iskov Kopp, El Maâti Allaoui, Pierrette Seeldrayers

Pharmacoepidemiol Drug Saf· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.
Lotte Geys, Tina Parciak, Ashkan Pirmani, Robert McBurney, Hollie Schmidt, Pierrette Seeldrayers

Int J MS Care· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis registries in Europe - An updated mapping survey.
A Glaser, A Stahmann, T Meissner, P Flachenecker, D Horáková, P Seeldrayers

Mult Scler Relat Disord· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management.
Brigitte Decallonne, Emmanuel Bartholomé, Valérie Delvaux, Miguel D'haeseleer, Souraya El Sankari, Pierrette Seeldrayers

Acta Neurol Belg· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study.
Lars Costers, Jeroen Gielen, Piet L Eelen, Jeroen Van Schependom, Jorne Laton, Pierrette Seeldrayers

Mult Scler Relat Disord· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis